Baird Capital Invests in Vodori
Today, Vodori announced that it secured $7.5 million in Series A funding led by Baird Capital’s venture team.
Chicago-based Vodori is a leading cloud software provider that empowers life science companies to bring vital drugs, vaccines, medical devices and diagnostic solutions to market faster. Vodori’s Pepper Cloud® Product Suite streamlines and automates how life science companies get critical content to key audiences including patients, healthcare providers and key opinion leaders.
“We are very excited to partner with the Vodori team and support their mission of accelerating life sciences companies’ commercialization efforts while also ensuring their regulatory compliance,” said Jim Pavlik, Partner with Baird Capital’s Venture Capital team. “We’ve been extremely impressed by Vodori’s intuitive and flexible suite of cloud-based solutions and look forward to leveraging our firm’s deep expertise and network in the life sciences and B2B software sectors to support the company in its next phase of growth.”
Read Vodori’s full news release here for more information.